Haag H et al. BMC Rheumatol 2018; 2: 9. doi: 10.1186/s41927-018-0017-8
Behçet syndrome: a contemporary view
In this review, the authors discuss the emerging, most-recent evidence on the etiology, manifestations and epidemiology of Behçet syndrome [read more]. Nat Rev Rheumatol 2018; 14: 107–119. doi: 10.1038/nrrheum.2017.208
Jobard et al postulated that giant cell arteritis (GCA) patients taking high dose corticosteroids had no significant impairment of quality of life (QOL) compared with controls in their study. GCA complications did not seem to have any major impact on QOL.
The authors determined that although several patient-reported outcomes have been identified additional work is needed to obtain a better insight into the required outcomes that incorporate the patient’s perspective.
Rheumatol Int 2016;36:897. doi:10.1007/s00296-015-3416-9